(14) noticed that BCT did not have survival benefit compared with mastectomy for young patients with breast cancer; however, the number of young patients in the study was relatively small and the results were only adjusted for tumor size, hormone receptor, HER2 and lymph nodes statuses. This evidence concerns the gene ERBB2 and breast cancer.